Composition and therapeutic anti-tumour vaccine

Details for Australian Patent Application No. 2008285595 (hide)

Owner Erytech Pharma

Inventors Godfrin, Yann; Banz, Alice

Agent Davies Collison Cave

Pub. Number AU-B-2008285595

PCT Pub. Number WO2009/019317

Priority 60/954,917 09.08.07 US; 0705767 08.08.07 FR

Filing date 8 August 2008

Wipo publication date 12 February 2009

Acceptance publication date 9 August 2012

International Classifications

A61K 35/18 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Erythrocytes

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 35/00 Antineoplastic agents

A61P 37/04 Drugs for immunological or allergic disorders

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019317 Priority application(s): WO2009/019317

4 March 2010 Amendment Made

  The nature of the amendment is: Amend the inventor name from Marchand, Alice to Banz, Alice

9 August 2012 Application Accepted

  Published as AU-B-2008285595

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285598-Method for inducing and accelerating cells

2008285590-Anti CD37 antibodies